homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Respiratory Disorders
Asthma & Allergic Rhinitis
COPD & Allied Disorders
Environmental & Occupational Lung Diseases
Extrapulmonary Disorders & Therapeutic Interventions
Interstitial Lung Diseases
Lung Cancer
Pulmonary Vascular Diseases
Respiratory Infections
Respiratory Pediatrics
Sleep & Ventilation Disorders
Related Sections
Respiratory Problems in Critical Care

profile subject selected for My F1000 Medicine

Browse > Respiratory Disorders > Lung Cancer
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 5. Select Page: 1 2 3 4 5 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0

Confirmation
 Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM, Herndon JE, …, Vokes EE, Green MR
J Clin Oncol 2008 Nov 1 26(31):5043-51 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Jack West
Evaluated 26 Nov 2008

Must Read
F1000 Factor 4.8

Hypothesis
New Finding
 Seeding and propagation of untransformed mouse mammary cells in the lung.
Podsypanina K, Du YC, …, Hambardzumyan D, Varmus H
Science 2008 Sep 26 321(5897):1841-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Larry Suva / Christos Sotiriou with Michail Ignatiadis
First evaluation 7 Nov 2008 | Latest evaluation 11 Nov 2008


Must Read
F1000 Factor 6.0

New Finding
 The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).
Karapanagiotou EM, Tsochatzis EA, …, Gratsias I, Syrigos KN
Lung Cancer 2008 Sep 61(3):391-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Andreina Bruno
Evaluated 7 Nov 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ, Bryant AS
Ann Thorac Surg 2008 Aug 86(2):362-6; discussion 366-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Sam Janes with Neal Navani
Evaluated 23 Oct 2008

Must Read
F1000 Factor 4.8

Confirmation
New Finding
 Missed opportunities for interval empathy in lung cancer communication.
Morse DS, Edwardsen EA, Gordon HS
Arch Intern Med 2008 Sep 22 168(17):1853-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Toby Campbell / Mellar Davis
First evaluation 16 Oct 2008 | Latest evaluation 18 Nov 2008

Recommended
F1000 Factor 3.0

Confirmation
 Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Zhu CQ, da Cunha Santos G, …, Tsao MS, National Cancer Institute of Canada Clinical Trials Group Study BR.21
J Clin Oncol 2008 Sep 10 26(26):4268-75 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Nico van Zandwijk
Evaluated 16 Oct 2008

Must Read
F1000 Factor 6.0

New Finding
 Association of radiographic emphysema and airflow obstruction with lung cancer.
Wilson DO, Weissfeld JL, …, Shapiro SD, Sciurba FC
Am J Respir Crit Care Med 2008 Oct 1 178(7):738-44 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Patrick Nana-Sinkam with Shiva Rahmanian
Evaluated 10 Oct 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies.
Thun MJ, Hannan LM, …, Wilkens LR, Samet JM
PLoS Med 2008 Sep 9 5(9):e185 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Ellen Chang
Evaluated 9 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
 Lung cancer in octogenarians: factors affecting long-term survival following resection.
Dominguez-Ventura A, Cassivi SD, …, Pairolero PC, Deschamps C
Eur J Cardiothorac Surg 2007 Aug 32(2):370-4 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Martine Extermann
Evaluated 29 Sep 2008

Recommended
F1000 Factor 3.0

New Finding
Controversial
 Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Früh M, Rolland E, …, Spiro S, Shepherd FA
J Clin Oncol 2008 Jul 20 26(21):3573-81 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Jack West
Evaluated 26 Sep 2008


top of pagePage 1 of 5. Select Page: 1 2 3 4 5 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info